Autophagy Revives Dying Cancer Cells

Self digestion thwarts self destruction.  

By | April 7, 2014

WIKIMEDIA, NATIONAL INSTITUTES OF HEALTHCancer cells in the throes of death, being ripped apart from the inside by apoptosis, can evidently survive and piece themselves back together. A study published last month (March 27) in Cell Reports and presented this week at the American Association for Cancer Research (AACR) meeting in San Diego, California, demonstrates how cancer cells with heightened autophagy can recover from such destruction. The results offer insight on how cancer cells might be able to withstand chemotherapy.

“The implication here is that if you inhibit autophagy you'd make this less likely to happen, i.e. when you kill cancer cells they would stay dead,” Andrew Thorburn, the senior author of the study and the deputy director of the University of Colorado Cancer Center, said in a press release.

Thorburn’s group looked at HeLa cells treated with a drug called TRAIL, which induces apoptosis. They found that augmenting autophagy in these cells leads to inefficiencies in an apoptotic process called mitochondrial outer membrane permeabilization (MOMP). Usually, cells break up within five minutes of MOMP. But when autophagy was increased, MOMP slugged along, leading to slower cell death and an opportunity for cellular revival.

“Autophagy is complex and as yet not fully understood,” Thorburn said in the release. “But now that we see a molecular mechanism whereby cell-fate can be determined by autophagy, we hope to discover patient populations that could benefit from drugs that inhibit this action.”

Check out this video of a cell ressurected from apoptosis.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham